Literature DB >> 8009960

Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.

M A Morán1, E J Mufson, P Gómez-Ramos.   

Abstract

Acetylcholinesterase and butyrylcholinesterase have been associated with structures undergoing neurofibrillary degeneration, as well as with all types of senile plaques, in non-demented aged and Alzheimer's brains. At the electron microscope level, the reaction product of both enzymes, appeared to decorate paired helical filaments, straight filaments and beta A4 amyloid fibrils. Recent studies showed that cholinesterases were associated with amyloid at early stages, e.g., in diffuse plaques. In the present study, the interrelationship of cholinesterases to structures undergoing neurofibrillary degeneration was analyzed further. Tau immunoreactivity was compared to the staining pattern observed with the two esterases. Double protocols consecutively performed on the same sections, and counterstaining with thioflavin-S, confirmed the presence of cholinesterases in all structures with neurofibrillary degeneration. The conclusion that cholinesterases consistently colocalize with both neurofibrillary bundles and beta A4 amyloid fibrils at all stages of their accumulation, allows us to speculate on the possible role that these enzymes may play in either the formation or the consolidation of fibrillary aggregates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009960     DOI: 10.1007/BF00296744

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  54 in total

1.  Microtubular reorganization and dendritic growth response in Alzheimer's disease.

Authors:  A C McKee; N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1989-11       Impact factor: 10.422

2.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.

Authors:  C I Wright; C Guela; M M Mesulam
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

5.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

6.  Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class.

Authors:  S H Yen; F Gaskin; S M Fu
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

7.  Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.

Authors:  A E Coleman; C Geula; B H Price; M M Mesulam
Journal:  Brain Res       Date:  1992-11-20       Impact factor: 3.252

8.  Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.

Authors:  M M Mesulam; C Geula; M A Morán
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

9.  Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure.

Authors:  H Tago; H Kimura; T Maeda
Journal:  J Histochem Cytochem       Date:  1986-11       Impact factor: 2.479

10.  Plasticity of hippocampal circuitry in Alzheimer's disease.

Authors:  J W Geddes; D T Monaghan; C W Cotman; I T Lott; R C Kim; H C Chui
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

View more
  9 in total

1.  Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Hiroyasu Akatsu; Eric E Abrahamson; Zhiping Mi; Milos D Ikonomovic
Journal:  Neuropathology       Date:  2015-08-21       Impact factor: 1.906

Review 2.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

3.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

4.  Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.

Authors:  Alexis Ciro; Joon Park; Gary Burkhard; Nicole Yan; Changiz Geula
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

5.  Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

Authors:  María-Ximena Silveyra; Geneviève Evin; María-Fernanda Montenegro; Cecilio J Vidal; Salvador Martínez; Janetta G Culvenor; Javier Sáez-Valero
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

6.  Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex.

Authors:  M A Morán; A Probst; C Navarro; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.

Authors:  Sergey O Bachurin; Galina F Makhaeva; Elena F Shevtsova; Natalia P Boltneva; Nadezhda V Kovaleva; Sofya V Lushchekina; Elena V Rudakova; Ludmila G Dubova; Daria V Vinogradova; Vladimir B Sokolov; Alexey Yu Aksinenko; Vladimir P Fisenko; Rudy J Richardson; Gjumrakch Aliev
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

8.  Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.

Authors:  Galina F Makhaeva; Nadezhda V Kovaleva; Natalia P Boltneva; Elena V Rudakova; Sofya V Lushchekina; Tatiana Yu Astakhova; Igor V Serkov; Alexey N Proshin; Eugene V Radchenko; Vladimir A Palyulin; Jan Korabecny; Ondrej Soukup; Sergey O Bachurin; Rudy J Richardson
Journal:  Molecules       Date:  2022-02-04       Impact factor: 4.411

9.  New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment.

Authors:  Galina F Makhaeva; Nadezhda V Kovaleva; Natalia P Boltneva; Sofya V Lushchekina; Tatiana Yu Astakhova; Elena V Rudakova; Alexey N Proshin; Igor V Serkov; Eugene V Radchenko; Vladimir A Palyulin; Sergey O Bachurin; Rudy J Richardson
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.